nach oben

Endocrine

Erschienen in:

19.08.2023 | Original Article

Prevalence and predictors of vitamin D deficiency in Lebanon: 2016–2022, before and during the COVID-19 outbreak

verfasst von: Diala Harkous, Nada Ghorayeb, Marie-Hélène Gannagé-Yared

Erschienen in: Endocrine | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Vitamin D deficiency is very common worldwide, particularly in Middle-Eastern countries. Recent Lebanese studies demonstrated an improvement in vitamin D status over time. However, the comparison between the years before and during the COVID-19 outbreak has never been analyzed in the Middle-East area. This study aimed to determine the prevalence and the predictors of 25-hydroxyvitamin D (25(OH)D) levels during the last 7 years.

Methods

Serum 25(OH)D levels from a large laboratory database were retrospectively collected from Hôtel-Dieu de France Hospital between January 2016 and June 2022 (N = 66,127). Data related to age, gender, season and year of sampling were also retrieved.

Results

Mean age of the population was 50.6 ± 19 years, 62.7% were women, 5.3% were children and adolescents, 67.6% adults and 27% elderly. Mean serum 25(OH)D level was 25.7 ± 11.9 ng/mL. The overall population with vitamin D sufficiency (>30 ng/mL) was 31.9%. The increase in mean serum 25(OH)D observed between 2016 and 2022 was 6.36 ng/mL (p < 0.0001). The prevalence of 25(OH)D deficiency (<30 ng/mL) decreased from 76.2% in 2016 to 56.5% in 2022 (p < 0.0001) with a significant difference between the period before and during the COVID-19 outbreak (72.3% vs.42.5%, p < 0.0001). In a multivariate logistic regression, older age, female sex, summer season, years of the COVID-19 outbreak and outpatient samples were protective factors against the risk of hypovitaminosis D (p < 0.0001 for all variables).

Conclusion

Our study showed a continuous positive change in vitamin D status time, most notably after the COVID-19 outbreak. Further studies are needed to assess the clinical impact of the pandemic on vitamin D status in our population.

A. Zendehdel, M. Arefi, Molecular evidence of role of vitamin D deficiency in various extraskeletal diseases. J. Cell Biochem. 120(6), 8829–8840 (2019). https://doi.org/10.1002/jcb.28185CrossRefPubMed

R. Bouillon, C. Marcocci, G. Carmeliet, D. Bikle, J.H. White, B. Dawson-Hughes et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 40(4), 1109–1151 (2019). https://doi.org/10.1210/er.2018-00126CrossRefPubMed

H. Glerup, K. Mikkelsen, L. Poulsen, E. Hass, S. Overbeck, J. Thomsen et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J. Intern. Med. 247(2), 260–268 (2000). https://doi.org/10.1046/j.1365-2796.2000.00595.xCrossRefPubMed

J. Bartley, Vitamin D: emerging roles in infection and immunity. Expert Rev. Anti Infect. Ther. 8(12), 1359–1369 (2010). https://doi.org/10.1586/eri.10.102CrossRefPubMed

D. Bassil, M. Rahme, M. Hoteit, G.E.H. Fuleihan, Hypovitaminosis D in the Middle East and North Africa: prevalence, risk factors and impact on outcomes. Dermatoendocrinol 5(2), 274–298 (2013). https://doi.org/10.4161/derm.25111CrossRefPubMedPubMedCentral

A.A. Yates, S.A. Schlicker, C.W. Suitor, Dietary Reference Intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J. Am. Diet. Assoc. 98(6), 699–706 (1998). https://doi.org/10.1016/S0002-8223(98)00160-6CrossRefPubMed

K. Amrein, M. Scherkl, M. Hoffmann, S. Neuwersch-Sommeregger, M. Köstenberger, A. Tmava Berisha et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr. 74(11), 1498–1513 (2020). https://doi.org/10.1038/s41430-020-0558-yCrossRefPubMedPubMedCentral

A.C. Ross, J.E. Manson, S.A. Abrams, J.F. Aloia, P.M. Brannon, S.K. Clinton et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96(1), 53–58 (2011). https://doi.org/10.1210/jc.2010-2704CrossRefPubMed

H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, B. Dawson-Hughes, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am. J. Clin. Nutr. 84(1), 18–28 (2006). https://doi.org/10.1093/ajcn/84.1.18CrossRefPubMed

10.

P. Lips, K.D. Cashman, C. Lamberg-Allardt, H.A. Bischoff-Ferrari, B. Obermayer-Pietsch, M.L. Bianchi et al. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified Tissue Society. Eur. J. Endocrinol. 180(4), P23–P54 (2019). https://doi.org/10.1530/EJE-18-0736CrossRefPubMed

11.

A.N. Hussain, A.H. Alkhenizan, M. El Shaker, H. Raef, A. Gabr, Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia. Arch. Osteoporos. 9, 190 (2014). https://doi.org/10.1007/s11657-014-0190-3CrossRefPubMed

12.

M.H. Gannagé-Yared, R. Chemali, N. Yaacoub, G. Halaby, Hypovitaminosis D in a sunny country: relation to lifestyle and bone markers. J. Bone Min. Res. 15(9), 1856–1862 (2000). https://doi.org/10.1359/jbmr.2000.15.9.1856CrossRef

13.

M.H. Gannagé-Yared, E. Helou, V. Zaraket, S. Abi Akl, L. Antonios, M.L. Moussalli et al. Serum 25 hydroxyvitamin D in employees of a Middle Eastern university hospital. J. Endocrinol. Invest. 37(6), 541–546 (2014). https://doi.org/10.1007/s40618-014-0061-1CrossRefPubMed

14.

A. Arabi, R. El Rassi, G. El-Hajj Fuleihan, Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat. Rev. Endocrinol. 6(10), 550–561 (2010). https://doi.org/10.1038/nrendo.2010.146CrossRefPubMed

15.

R.K. Saad, V.C. Akiki, M. Rahme, S. Ajjour, M. Assaad, G.A. El-Hajj Fuleihan, Time trends and predictors of hypovitaminosis D across the life course: 2009-2016. Metabolism 105, 154138 (2020). https://doi.org/10.1016/j.metabol.2020.154138CrossRefPubMed

16.

M. Hoteit, L. Al-Shaar, C. Yazbeck, M. Bou Sleiman, T. Ghalayini, G.E.H. Fuleihan, Hypovitaminosis D in a sunny country: time trends, predictors, and implications for practice guidelines. Metabolism 63(7), 968–978 (2014). https://doi.org/10.1016/j.metabol.2014.04.009CrossRefPubMed

17.

P. Lips, R.T. de Jongh, N.M. van Schoor, Trends in vitamin D status around the world. JBMR Plus 5(12), e10585 (2021). https://doi.org/10.1002/jbm4.10585CrossRefPubMedPubMedCentral

18.

R.L. Schleicher, M.R. Sternberg, D.A. Lacher, C.T. Sempos, A.C. Looker, R.A. Durazo-Arvizu et al. The vitamin D status of the US population from 1988 to 2010 using standardized serum concentrations of 25-hydroxyvitamin D shows recent modest increases. Am. J. Clin. Nutr. 104(2), 454–461 (2016). https://doi.org/10.3945/ajcn.115.127985CrossRefPubMedPubMedCentral

19.

M. Pereira, A. Dantas Damascena, L.M. Galvão Azevedo, T. de Almeida Oliveira, J. da Mota Santana, Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 62(5), 1308–1316 (2022). https://doi.org/10.1080/10408398.2020.1841090CrossRefPubMed

20.

J.M. Rhodes, S. Subramanian, E. Laird, G. Griffin, R.A. Kenny, Perspective: vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis. J. Intern. Med. 289(1), 97–115 (2021). https://doi.org/10.1111/joim.13149CrossRefPubMed

21.

E. Cereda, L. Bogliolo, C. Klersy, F. Lobascio, S. Masi, S. Crotti et al. Vitamin D 25OH deficiency in COVID-19 patients admitted to a tertiary referral hospital. Clin. Nutr. Edinb. Scotl. 40(4), 2469–2472 (2021). https://doi.org/10.1016/j.clnu.2020.10.055CrossRef

22.

G.E. Carpagnano, V. Di Lecce, V.N. Quaranta, A. Zito, E. Buonamico, E. Capozza et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J. Endocrinol. Invest. 44(4), 765–771 (2021). https://doi.org/10.1007/s40618-020-01370-xCrossRefPubMed

23.

A. Radujkovic, T. Hippchen, S. Tiwari-Heckler, S. Dreher, M. Boxberger, U. Merle, Vitamin D deficiency and outcome of COVID-19 patients. Nutrients 12(9), E2757 (2020). https://doi.org/10.3390/nu12092757CrossRef

24.

S. Sabico, M.A. Enani, E. Sheshah, N.J. Aljohani, D.A. Aldisi, N.H. Alotaibi et al. Effects of a 2-week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate COVID-19: a randomized clinical trial. Nutrients 13(7), 2170 (2021). https://doi.org/10.3390/nu13072170CrossRefPubMedPubMedCentral

25.

M. Miraglia Del Giudice, C. Indolfi, G. Dinardo, F. Decimo, A. Decimo, A. Klain, Vitamin D status can affect COVID-19 outcomes also in pediatric population. PharmaNutrition 22, 100319 (2022). https://doi.org/10.1016/j.phanu.2022.100319CrossRefPubMedPubMedCentral

26.

A. Puścion-Jakubik, J. Bielecka, M. Grabia, A. Mielech, R. Markiewicz-Żukowska, K. Mielcarek et al. Consumption of food supplements during the three COVID-19 waves in Poland-focus on zinc and vitamin D. Nutrients 13(10), 3361 (2021). https://doi.org/10.3390/nu13103361CrossRefPubMedPubMedCentral

27.

S. Çimke, D. Yıldırım Gürkan, Determination of interest in vitamin use during COVID-19 pandemic using Google Trends data: infodemiology study. Nutrition 85, 111138 (2021). https://doi.org/10.1016/j.nut.2020.111138CrossRefPubMedPubMedCentral

28.

M. Mikulic, Change in usage of dietary supplements due to COVID-19 among U.S. adults as of August 2020, by gender. https://www.statista.com/statistics/1180357/dietary-supplement-usage-change-due-to-covid-us-adults-by-gender/

29.

H. Mohsen, N. Yazbeck, A. Al-Jawaldeh, N. Bou Chahine, H. Hamieh, Y. Mourad et al. Knowledge, attitudes, and practices related to dietary supplementation, before and during the COVID-19 pandemic: findings from a cross-sectional survey in the Lebanese population. Int. J. Environ. Res. Public Health 18(16), 8856 (2021). https://doi.org/10.3390/ijerph18168856CrossRefPubMedPubMedCentral

30.

R.S. Wong, K.T.S. Tung, H.K. So, W.H.S. Wong, S.Y. Wong, H.W. Tsang et al. Impact of COVID-19 pandemic on serum vitamin D level among infants and toddlers: an interrupted time series analysis and before-and-after comparison. Nutrients 13(4), 1270 (2021). https://doi.org/10.3390/nu13041270CrossRefPubMedPubMedCentral

31.

L. Yu, H.J. Ke, D. Che, S.L. Luo, Y. Guo, J.L. Wu, Effect of pandemic-related confinement on vitamin D status among children aged 0-6 years in Guangzhou, China: a cross-sectional study. Risk Manag. Healthc. Policy 13, 2669–2675 (2020). https://doi.org/10.2147/RMHP.S282495CrossRefPubMedPubMedCentral

32.

A.R. Bizri, H.H. Khachfe, M.Y. Fares, U. Musharrafieh, COVID-19 pandemic: an insult over injury for Lebanon. J. Community Health 46(3), 487–493 (2021). https://doi.org/10.1007/s10900-020-00884-yCrossRefPubMed

33.

K.A. Herrick, R.J. Storandt, J. Afful, C.M. Pfeiffer, R.L. Schleicher, J.J. Gahche et al. Vitamin D status in the United States, 2011-2014. Am. J. Clin. Nutr. 110(1), 150–157 (2019). https://doi.org/10.1093/ajcn/nqz037CrossRefPubMedPubMedCentral

34.

D.M. Mitchell, K. Ruppert, N. Udupa, F. Bassir, K. Darakananda, D.H. Solomon et al. Temporal increases in 25-hydroxyvitamin D in midlife women: longitudinal results from the Study of Women’s Health Across the Nation. Clin. Endocrinol. (Oxf.) 91(1), 48–57 (2019). https://doi.org/10.1111/cen.13986CrossRefPubMed

35.

T. Jääskeläinen, S.T. Itkonen, A. Lundqvist, M. Erkkola, T. Koskela, K. Lakkala et al. The positive impact of general vitamin D food fortification policy on vitamin D status in a representative adult Finnish population: evidence from an 11-y follow-up based on standardized 25-hydroxyvitamin D data. Am. J. Clin. Nutr. 105(6), 1512–1520 (2017). https://doi.org/10.3945/ajcn.116.151415CrossRefPubMed

36.

S. Andersen, P. Laurberg, B. Hvingel, K. Kleinschmidt, L. Heickendorff, L. Mosekilde, Vitamin D status in Greenland is influenced by diet and ethnicity: a population-based survey in an Arctic society in transition. Br. J. Nutr. 109(5), 928–935 (2013). https://doi.org/10.1017/S0007114512002097CrossRefPubMed

37.

H. Khosravi-Boroujeni, N. Sarrafzadegan, M. Sadeghi, H. Roohafza, S.K. Ng, A. Pourmogaddas et al. Prevalence and trends of vitamin D deficiency among Iranian adults: a longitudinal study from 2001–2013. J. Nutr. Sci. Vitaminol. (Tokyo) 63(5), 284–290 (2017). https://doi.org/10.3177/jnsv.63.284CrossRefPubMed

38.

N.M. Al-Daghri, S.D. Hussain, M.G.A. Ansari, M.N.K. Khattak, N. Aljohani, Y. Al-Saleh, et al. Decreasing prevalence of vitamin D deficiency in the central region of Saudi Arabia (2008-2017). J. Steroid Biochem. Mol. Biol. 212, 105920 (2021). https://doi.org/10.1016/j.jsbmb.2021.105920CrossRefPubMed

39.

M. Chakhtoura, W.D. Leslie, M. McClung, A.M. Cheung, G.E.H. Fuleihan, The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos. Int. 28(1), 127–137 (2017). https://doi.org/10.1007/s00198-016-3766-5CrossRefPubMed

40.

R. Lordan, Dietary supplements and nutraceuticals market growth during the coronavirus pandemic – implications for consumers and regulatory oversight. PharmaNutrition 18, 100282 (2021). https://doi.org/10.1016/j.phanu.2021.100282CrossRefPubMedPubMedCentral

41.

J. Hamulka, M. Jeruszka-Bielak, M. Górnicka, M.E. Drywień, M.A. Zielinska-Pukos, Dietary supplements during COVID-19 outbreak. Results of Google Trends analysis supported by PLifeCOVID-19 online studies. Nutrients 13(1), E54 (2020). https://doi.org/10.3390/nu13010054CrossRef

42.

W.B. Grant, H. Lahore, S.L. McDonnell, C.A. Baggerly, C.B. French, J.L. Aliano et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12(4), E988 (2020). https://doi.org/10.3390/nu12040988CrossRef

43.

G. El-Hajj Fuleihan, R. Baddoura, H. Awada, A. Arabi, J. Okais, First update of the Lebanese guidelines for osteoporosis assessment and treatment. J. Clin. Densitom. 11(3), 383–396 (2008). https://doi.org/10.1016/j.jocd.2008.02.006CrossRefPubMed

44.

H.A. Algaeed, M.I. AlJaber, A.I. Alwehaibi, L.I. AlJaber, A.M. Arafah, M.A. Aloyayri et al. General public knowledge and use of dietary supplements in Riyadh, Saudi Arabia. J. Fam. Med Prim. Care 8(10), 3147–3154 (2019). https://doi.org/10.4103/jfmpc.jfmpc_511_19CrossRef

45.

S. Hussain, M. Elnajeh, Prevalence and risk factors for hypovitaminosis D among healthy adolescents in Kota Bharu, Kelantan. J. ASEAN Fed. Endocr. Soc. 35(2), 176–180 (2020). https://doi.org/10.15605/jafes.035.02.05CrossRefPubMedPubMedCentral

46.

H.A. Alfawaz, N. Khan, G.A. Aljumah, S.D. Hussain, N.M. Al-Daghri, Dietary intake and supplement use among Saudi residents during COVID-19 lockdown. Int J. Environ. Res. Public Health 18(12), 6435 (2021). https://doi.org/10.3390/ijerph18126435CrossRefPubMedPubMedCentral

47.

P. D’Amelio, L. Quacquarelli, Hypovitaminosis D and aging: is there a role in muscle and brain health? Nutrients 12(3), E628 (2020). https://doi.org/10.3390/nu12030628CrossRef

48.

M.H. Gannagé-Yared, G. Maalouf, S. Khalife, S. Challita, Y. Yaghi, N. Ziade et al. Prevalence and predictors of vitamin D inadequacy amongst Lebanese osteoporotic women. Br. J. Nutr. 101(4), 487–491 (2009). https://doi.org/10.1017/S0007114508023404CrossRefPubMed

49.

N.M. Al-Daghri, O.S. Al-Attas, M.S. Alokail, K.M. Alkharfy, E. El-Kholie, M. Yousef et al. Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents. Clin. Endocrinol. (Oxf.) 76(3), 346–350 (2012). https://doi.org/10.1111/j.1365-2265.2011.04219.xCrossRefPubMed

50.

S.A. Quraishi, C.A. Camargo, Vitamin D in acute stress and critical illness. Curr. Opin. Clin. Nutr. Metab. Care 15(6), 625–634 (2012). https://doi.org/10.1097/MCO.0b013e328358fc2bCrossRefPubMedPubMedCentral

Titel: Prevalence and predictors of vitamin D deficiency in Lebanon: 2016–2022, before and during the COVID-19 outbreak
verfasst von: Diala Harkous
Nada Ghorayeb
Marie-Hélène Gannagé-Yared
Publikationsdatum: 19.08.2023
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-023-03483-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Prevalence and predictors of vitamin D deficiency in Lebanon: 2016–2022, before and during the COVID-19 outbreak

Abstract

Background

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2023

Understanding the characteristics of idiopathic osteoporosis by a systematic review and meta-analysis

The expression of two immunosuppressive SIGLEC family molecules in papillary thyroid cancer and their effect on prognosis

Risk factors for death of follicular thyroid carcinoma: a systematic review and meta-analysis

Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome

Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism

The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin